Report Overview
Report Overview
Nuclear Medicine,or Radiopharmaceuticals, are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.Market DriversThe nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the markets expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.Market ChallengesDespite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
The global Nuclear Medicine market size was estimated at USD 6875.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclear Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclear Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclear Medicine market.
Global Nuclear Medicine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
Market Segmentation (by Type)
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Market Segmentation (by Application)
Oncology
Thyroid
Cardiology
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nuclear Medicine Market
Overview of the regional outlook of the Nuclear Medicine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclear Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Nuclear Medicine and Radiopharmaceuticals
- 1.2 Key Market Segments
- 1.2.1 Nuclear Medicine and Radiopharmaceuticals Segment by Type
- 1.2.2 Nuclear Medicine and Radiopharmaceuticals Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Nuclear Medicine and Radiopharmaceuticals Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Nuclear Medicine and Radiopharmaceuticals Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Nuclear Medicine and Radiopharmaceuticals Product Life Cycle
- 3.3 Global Nuclear Medicine and Radiopharmaceuticals Sales by Manufacturers (2020-2025)
- 3.4 Global Nuclear Medicine and Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Nuclear Medicine and Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Nuclear Medicine and Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Nuclear Medicine and Radiopharmaceuticals Market Competitive Situation and Trends
- 3.8.1 Nuclear Medicine and Radiopharmaceuticals Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Nuclear Medicine and Radiopharmaceuticals Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Nuclear Medicine and Radiopharmaceuticals Industry Chain Analysis
- 4.1 Nuclear Medicine and Radiopharmaceuticals Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Nuclear Medicine and Radiopharmaceuticals Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Nuclear Medicine and Radiopharmaceuticals Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Nuclear Medicine and Radiopharmaceuticals Market
- 5.7 ESG Ratings of Leading Companies
- 6 Nuclear Medicine and Radiopharmaceuticals Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Type (2020-2025)
- 6.3 Global Nuclear Medicine and Radiopharmaceuticals Market Size by Type (2020-2025)
- 6.4 Global Nuclear Medicine and Radiopharmaceuticals Price by Type (2020-2025)
- 7 Nuclear Medicine and Radiopharmaceuticals Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Nuclear Medicine and Radiopharmaceuticals Market Sales by Application (2020-2025)
- 7.3 Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
- 7.4 Global Nuclear Medicine and Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
- 8 Nuclear Medicine and Radiopharmaceuticals Market Sales by Region
- 8.1 Global Nuclear Medicine and Radiopharmaceuticals Sales by Region
- 8.1.1 Global Nuclear Medicine and Radiopharmaceuticals Sales by Region
- 8.1.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Region
- 8.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region
- 8.2.1 Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region
- 8.2.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region
- 8.3 North America
- 8.3.1 North America Nuclear Medicine and Radiopharmaceuticals Sales by Country
- 8.3.2 North America Nuclear Medicine and Radiopharmaceuticals Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Nuclear Medicine and Radiopharmaceuticals Sales by Country
- 8.4.2 Europe Nuclear Medicine and Radiopharmaceuticals Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Nuclear Medicine and Radiopharmaceuticals Sales by Region
- 8.5.2 Asia Pacific Nuclear Medicine and Radiopharmaceuticals Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Nuclear Medicine and Radiopharmaceuticals Sales by Country
- 8.6.2 South America Nuclear Medicine and Radiopharmaceuticals Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales by Region
- 8.7.2 Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Nuclear Medicine and Radiopharmaceuticals Sales by Region
- 9 Nuclear Medicine and Radiopharmaceuticals Market Production by Region
- 9.1 Global Production of Nuclear Medicine and Radiopharmaceuticals by Region(2020-2025)
- 9.2 Global Nuclear Medicine and Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
- 9.3 Global Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Nuclear Medicine and Radiopharmaceuticals Production
- 9.4.1 North America Nuclear Medicine and Radiopharmaceuticals Production Growth Rate (2020-2025)
- 9.4.2 North America Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Nuclear Medicine and Radiopharmaceuticals Production
- 9.5.1 Europe Nuclear Medicine and Radiopharmaceuticals Production Growth Rate (2020-2025)
- 9.5.2 Europe Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Nuclear Medicine and Radiopharmaceuticals Production (2020-2025)
- 9.6.1 Japan Nuclear Medicine and Radiopharmaceuticals Production Growth Rate (2020-2025)
- 9.6.2 Japan Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Nuclear Medicine and Radiopharmaceuticals Production (2020-2025)
- 9.7.1 China Nuclear Medicine and Radiopharmaceuticals Production Growth Rate (2020-2025)
- 9.7.2 China Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Cardinal Health
- 10.1.1 Cardinal Health Basic Information
- 10.1.2 Cardinal Health Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.1.3 Cardinal Health Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.1.4 Cardinal Health Business Overview
- 10.1.5 Cardinal Health SWOT Analysis
- 10.1.6 Cardinal Health Recent Developments
- 10.2 GE Healthcare
- 10.2.1 GE Healthcare Basic Information
- 10.2.2 GE Healthcare Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.2.3 GE Healthcare Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.2.4 GE Healthcare Business Overview
- 10.2.5 GE Healthcare SWOT Analysis
- 10.2.6 GE Healthcare Recent Developments
- 10.3 Jubilant Pharma
- 10.3.1 Jubilant Pharma Basic Information
- 10.3.2 Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.3.3 Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.3.4 Jubilant Pharma Business Overview
- 10.3.5 Jubilant Pharma SWOT Analysis
- 10.3.6 Jubilant Pharma Recent Developments
- 10.4 Novartis
- 10.4.1 Novartis Basic Information
- 10.4.2 Novartis Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.4.3 Novartis Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.4.4 Novartis Business Overview
- 10.4.5 Novartis Recent Developments
- 10.5 Curium Pharma
- 10.5.1 Curium Pharma Basic Information
- 10.5.2 Curium Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.5.3 Curium Pharma Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.5.4 Curium Pharma Business Overview
- 10.5.5 Curium Pharma Recent Developments
- 10.6 SIEMENS
- 10.6.1 SIEMENS Basic Information
- 10.6.2 SIEMENS Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.6.3 SIEMENS Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.6.4 SIEMENS Business Overview
- 10.6.5 SIEMENS Recent Developments
- 10.7 Lantheus
- 10.7.1 Lantheus Basic Information
- 10.7.2 Lantheus Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.7.3 Lantheus Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.7.4 Lantheus Business Overview
- 10.7.5 Lantheus Recent Developments
- 10.8 Bracco Imaging
- 10.8.1 Bracco Imaging Basic Information
- 10.8.2 Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.8.3 Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.8.4 Bracco Imaging Business Overview
- 10.8.5 Bracco Imaging Recent Developments
- 10.9 Bayer
- 10.9.1 Bayer Basic Information
- 10.9.2 Bayer Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.9.3 Bayer Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.9.4 Bayer Business Overview
- 10.9.5 Bayer Recent Developments
- 10.10 Eli Lilly
- 10.10.1 Eli Lilly Basic Information
- 10.10.2 Eli Lilly Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.10.3 Eli Lilly Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.10.4 Eli Lilly Business Overview
- 10.10.5 Eli Lilly Recent Developments
- 10.11 Aurobindo Pharma
- 10.11.1 Aurobindo Pharma Basic Information
- 10.11.2 Aurobindo Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.11.3 Aurobindo Pharma Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.11.4 Aurobindo Pharma Business Overview
- 10.11.5 Aurobindo Pharma Recent Developments
- 10.12 Mundipharma
- 10.12.1 Mundipharma Basic Information
- 10.12.2 Mundipharma Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.12.3 Mundipharma Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.12.4 Mundipharma Business Overview
- 10.12.5 Mundipharma Recent Developments
- 10.13 China Isotope and Radiation
- 10.13.1 China Isotope and Radiation Basic Information
- 10.13.2 China Isotope and Radiation Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.13.3 China Isotope and Radiation Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.13.4 China Isotope and Radiation Business Overview
- 10.13.5 China Isotope and Radiation Recent Developments
- 10.14 Dongcheng
- 10.14.1 Dongcheng Basic Information
- 10.14.2 Dongcheng Nuclear Medicine and Radiopharmaceuticals Product Overview
- 10.14.3 Dongcheng Nuclear Medicine and Radiopharmaceuticals Product Market Performance
- 10.14.4 Dongcheng Business Overview
- 10.14.5 Dongcheng Recent Developments
- 10.1 Cardinal Health
- 11 Nuclear Medicine and Radiopharmaceuticals Market Forecast by Region
- 11.1 Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast
- 11.2 Global Nuclear Medicine and Radiopharmaceuticals Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country
- 11.2.3 Asia Pacific Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Region
- 11.2.4 South America Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Nuclear Medicine and Radiopharmaceuticals by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Nuclear Medicine and Radiopharmaceuticals Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Nuclear Medicine and Radiopharmaceuticals by Type (2026-2035)
- 12.1.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Nuclear Medicine and Radiopharmaceuticals by Type (2026-2035)
- 12.2 Global Nuclear Medicine and Radiopharmaceuticals Market Forecast by Application (2026-2035)
- 12.2.1 Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) Forecast by Application
- 12.2.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Nuclear Medicine and Radiopharmaceuticals Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings